Tel:
Fax:
Email:
Creative Biolabs

Psychiatric Disease Mouse Model Development Services

Are you currently facing long drug development cycles or difficulty in accurately modeling complex psychiatric disorders? Our psychiatric disease mouse models development services help you accelerate neuroscience research and obtain high-fidelity preclinical data through advanced genetic engineering, comprehensive behavioral phenotyping, and integrated multi-omics analysis.

Psychiatric disorders are complex conditions influenced by intricate genetic predispositions and environmental factors. Developing accurate experimental models is paramount for dissecting their pathophysiology and identifying novel therapeutic interventions. Psychiatric disease mouse models serve as invaluable tools for this purpose, enabling objective measurement of disease hallmarks and associated genes that are often challenging to ascertain in human clinical diagnoses. These models are crucial for bridging the gap between basic neuroscience and clinical translation.

Workflow Advantages Available Models Offerings Related Services

How Our Psychiatric Disease Mouse Models Development Services Can Assist Your Project

At Creative Biolabs, we provide specific, actionable solutions designed to overcome the inherent complexities of psychiatric drug discovery. Our services deliver meticulously characterized mouse models that are essential for target identification, lead optimization, and preclinical efficacy testing. You can expect models that closely reflect human disease pathology, enabling more predictive and translatable research outcomes.

Discover How We Can Help - Request a Consultation Today!

Workflow

Our comprehensive workflow is designed for transparency and efficiency, guiding your project from initial concept to robust data.

  • Required Starting Materials: To initiate a project, clients typically provide detailed project objectives, specific target genes or pathways of interest, and any available human genetic or clinical data relevant to the disorder being modeled. For custom model generation, information on desired genetic modifications (e.g., specific point mutations, gene knockout strategies) is crucial.

Fig.1 Workflow of our Psychiatric Disease Mouse Models Development Services. (Creative Biolabs Original)

  • Final Deliverables: Clients receive a comprehensive study report, including detailed experimental protocols, raw data files, statistical analyses, and a clear interpretation of findings. We also provide genetically validated mouse lines for future research, where applicable.
  • Estimated Timeframe: The typical timeframe for this service ranges from 16 to 48 weeks, depending on the complexity of the genetic modification, the scope of phenotyping, and the number of animal cohorts required. Projects involving novel genetic models may lean towards the longer end due to breeding and characterization phases.

Why Choose Us?

Choosing CBL means partnering with pioneers in preclinical neuroscience. Our commitment to scientific rigor, coupled with unparalleled expertise, ensures your projects yield reliable, actionable data that truly moves the needle in psychiatric drug discovery. We stand out through our integrated approach, combining advanced model generation with comprehensive behavioral and molecular phenotyping, ensuring a holistic understanding of disease pathology.

Experience the Advantage - Get a Quote Today!

Customer Reviews

  • [Exceptional Model Validity] Using CBL's psychiatric disease mouse models in our research has significantly improved the translational relevance of our findings, allowing us to identify a novel therapeutic candidate with strong in vivo efficacy. The detailed behavioral phenotyping data was invaluable for understanding compound mechanism. 10 months ago, Jame***on P.
  • [Streamlined Research Workflow] The comprehensive workflow provided by CBL facilitated our project significantly. Their expertise in CRISPR/Cas9 for custom model creation is unmatched, leading to substantial time savings and higher quality genetic models compared to our previous collaborations. 6 months ago, Li***a K.
  • [Unparalleled Support] The proactive communication and scientific guidance from the CBL team were exceptional. They helped us navigate complex experimental design challenges, providing critical insights that optimized our drug screening approach for anxiety disorders. 3 weeks ago, Rob***rt S.

Types of Psychiatric Disease Mouse Models

Our expertise extends across a spectrum of psychiatric conditions, enabling us to develop and validate models tailored to the unique characteristics of each disorder.

Models Description
Autism Spectrum Disorder (ASD) Mouse Models ASD are complex neurodevelopmental disorders characterized by challenges in social interaction, communication, and restricted, repetitive behaviors. We develop ASD mouse models through:
  • Genetic Modifications: Creating models with targeted mutations in candidate genes identified in human ASD patients (e.g., Shank3, Fmr1 knockout models).
  • Behavioral Phenotyping: Utilizing specialized tests to assess core ASD-like behaviors, including social interaction (three-chamber test, direct social interaction), repetitive behaviors (nesting, marble burying, stereotypies), and communication (ultrasonic vocalizations).
Schizophrenia Mouse Models Schizophrenia is a severe mental disorder with complex positive, negative, and cognitive symptoms. Addressing the unmet need for effective treatments, particularly for negative and cognitive symptoms, is a key focus. Our schizophrenia mouse models include:
  • Genetic Models: Targeting genes implicated in schizophrenia (e.g., DISC1, NRG1 models) to investigate neurodevelopmental and synaptic dysfunction. We prioritize models based on highly penetrant human genetic variants to enhance construct validity.
  • Drug-Induced Models: Utilizing pharmacological manipulations (e.g., NMDA receptor antagonists like PCP or ketamine, or dopamine agonists like amphetamine) to induce psychosis-like behaviors.
  • Behavioral Phenotyping: Assessing a range of behaviors relevant to schizophrenia, such as prepulse inhibition (PPI) for sensorimotor gating deficits, locomotor activity, and cognitive tasks like novel object recognition, with a focus on identifying intermediate phenotypes and endophenotypes that reflect underlying circuit dysfunctions.
Depression Mouse Models Depression significantly impacts quality of life, and new antidepressant therapies are critically needed. We offer robust models to study depressive-like behaviors:
  • Stress-Induced Models: Employing paradigms like Chronic Unpredictable Mild Stress (CUMS) or Chronic Social Defeat Stress to induce anhedonia, learned helplessness, and other depressive-like phenotypes.
  • Genetic Models: Investigating the role of specific genes and pathways implicated in mood regulation.
  • Behavioral Phenotyping: Utilizing tests such as the forced swim test, tail suspension test (for behavioral despair), and sucrose preference test (for anhedonia), along with assessing changes in body weight and circadian rhythms.
Anxiety Mouse Models Anxiety disorders are characterized by excessive nervousness, fear, and apprehension, often manifesting with physical symptoms. Our anxiety models allow for the evaluation of novel anxiolytic compounds:
  • Stress-Induced Models: Using acute or chronic stress paradigms to induce anxiety-like behaviors.
  • Pharmacological Models: Assessing the effects of anxiogenic or anxiolytic compounds.
  • Behavioral Phenotyping: Employing well-established tests like the elevated plus maze, light/dark box, open field test, and marble burying test to quantify anxiety-like behaviors and evaluate the efficacy of potential therapeutic agents.
Attention-Deficit/Hyperactivity Disorder (ADHD) Mouse Models ADHD is a neurodevelopmental disorder characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning or development. Our ADHD mouse models are designed to capture key behavioral and neurobiological features of the disorder:
  • Genetic Models: Developing models that involve genetic modifications to genes associated with ADHD in humans, such as those related to dopamine transport (e.g., DAT knockout models) or synaptic function (e.g., SNAP-25 models).
  • Pharmacological Models: Utilizing pharmacological interventions to induce hyperactivity or attentional deficits that mimic aspects of ADHD.
  • Behavioral Phenotyping: Employing specialized assays to assess core ADHD-like behaviors, including spontaneous locomotor activity, attention (e.g., five-choice serial reaction time task - 5-CSRTT), and impulsivity (e.g., delay discounting tasks). These assessments help evaluate the efficacy of potential therapeutic compounds.

What We Can Offer

At CBL, we empower your neuroscience research with a suite of robust capabilities designed for precision and scalability:

  • One-stop Mouse Model Development: We offer comprehensive services from initial model conceptualization and genetic design to final phenotyping and data analysis, providing a seamless workflow.
  • Efficient Model Generation & Characterization: Leveraging advanced genetic engineering tools like CRISPR/Cas9, we ensure rapid and precise creation of custom mouse models, followed by meticulous characterization to guarantee model stability and genetic integrity.
  • Scalable Capacity for Diverse Projects: Our state-of-the-art facilities and experienced team have the capacity to manage multiple projects simultaneously, from small-scale pilot studies to large-cohort preclinical trials, ensuring timely delivery for your research needs.
  • Rigorous Quality Control & Ethical Standards: We operate under a well-established Quality-by-Design (QbD) framework, employing process analytical techniques (PAT) and strict aseptic procedures to ensure the highest standards in animal welfare, experimental execution, and data quality.
  • Guaranteed Model Consistency: Our thorough assessment of strain origin and continuous monitoring of cell banks ensure the stability and consistent performance of our models across all phases, from initial breeding to large-scale studies.
  • Optimized Experimental Design: We continuously optimize our genetic modification strategies and behavioral assay conditions to maximize the yield of relevant phenotypes and ensure robust and reproducible results, whether in batch, fed-batch, or continuous study modes.
  • Advanced Quality Control Tools: We utilize cutting-edge phenotyping equipment and sophisticated analytical tools to quantify and evaluate the quality and relevance of the data generated from our mouse models, providing you with highly reliable outcomes.
  • Customized Service Excellence: Recognizing that each research project is unique, we emphasize personalized consultation and flexible service adaptation to meet your specific scientific objectives and project requirements.

Related Services

To further support your comprehensive research needs, CBL offers several complementary services that can be integrated with our psychiatric disease mouse models development:

Ready to advance your psychiatric disease research? Reach out to our expert team today to discuss your project specifics and discover how our tailored solutions can propel your program forward.

Contact Our Team for More Information and to Discuss Your Project.

For Research Use Only. Not For Clinical Use.
In Vivo Services
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
USA

Tel:

Fax:

Email:

UK

Tel:

Email:

Germany

Tel:

Email:

Inquiry Basket
compare

Send inquiry